Real-life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study.
Dragotto M, Capalbo E, Cartocci A, Manzo Margiotta F, Michelucci A, Rosi E, Ricceri F, Simoni B, Savarese I, Milanesi N, Rossari S, Magnano M, Romanelli M, Rubegni P, Prignano F, Di Cesare A, Panduri S, Pescitelli L, Trovato E.
Dragotto M, et al. Among authors: magnano m.
J Eur Acad Dermatol Venereol. 2023 Apr 16. doi: 10.1111/jdv.19117. Online ahead of print.
J Eur Acad Dermatol Venereol. 2023.
PMID: 37062048
No abstract available.